Our Mission

At Aurealcraft Inc., our mission with ConDrug is simple and ambitious: turn drug-safety data into trustworthy, decision-grade insight in minutes—every day, for everyone who protects patients.

We believe pharmacovigilance teams shouldn’t drown in PDFs, spreadsheets, and fragmented systems. They should ask a question and get a defensible answer—fast. ConDrug unifies daily-updated regulatory data (1939–present), rigorous normalization, and explainable AI so that safety scientists, regulators, and biopharma leaders can move from “search” to action with confidence.

Why We Exist

• Patients deserve speed and certainty. Signal detection and risk assessment must be timely, transparent, and replicable.
• Science should be the focus, not plumbing. We remove data wrangling and manual reporting so experts spend time on judgment, not busywork.
• Trust is earned. Our models explain their reasoning, cite sources, and keep humans in the loop.

What We Commit To

1. Evidence First. Daily refreshes, versioned datasets, and change logs so every conclusion can be traced and reproduced.
2. Explainable AI. Human-reviewed outputs, rationale summaries, and source citations; AI assists, you decide.
3. Audit-Readiness by Design. Branded PDF/CSV exports, role-based access, and retention policies that withstand inspection.
4. Security & Privacy. Encryption, strong access controls, regional data safeguards, and no PHI processing without a BAA.
5. Open, Interoperable Workflows. APIs, batch jobs, and integrations that fit your stack instead of forcing you into ours.
6. Global Reliability. High availability targets, measured performance, and support that speaks the language of PV and regulatory work.
7. Ethics & Safety. We refuse dark patterns, hidden training data claims, or black-box decisions in clinical contexts.

How We Measure Ourselves

• Time to Insight: Minutes from query to a defensible, cited answer.
• Uplift in Throughput: More cases, labels, and markets reviewed per analyst per week.
• Regulatory Confidence: Reports accepted in audits without rework.
• User Trust: Transparent accuracy metrics and rapid remediation when we fall short.

The Future We’re Building

ConDrug will keep expanding from labels and NDCs into richer post-marketing evidence, structured narratives, and collaborative review—so safety knowledge compounds instead of decaying. We will partner with biopharma, CROs, and regulators to standardize how AI supports pharmacovigilance: measurable quality, clear accountability, patient-first outcomes.

Our promise: Clarity, speed, and rigor—so your team can protect patients and advance medicines with confidence.